Individualized treatment with combination of Peg-interferon alpha 2b and ribavirin in patients with HCV genotype 3

Autor:	Mangia, A, Bandiera, F, Mottola, L, Piazzolla, V, Minerva, N, Pellicelli, A, Ricci, GL, Cela, M, Carretta, V, Scotto, G, Bacca, D, Annichiarico, B, Romano, N, Russello, M, Barbarini, G, Agostinacchio, E, Andriulli, A., MONTALTO, Giuseppe
Přispěvatelé:	Mangia, A, Bandiera, F, Montalto, G, Mottola, L, Piazzolla, V, Minerva, N, Pellicelli, A, Ricci, GL, Cela, M, Carretta, V, Scotto, G, Bacca, D, Annichiarico, B, Romano, N, Russello, M, Barbarini, G, Agostinacchio, E, Andriulli, A
Jazyk:	angličtina
Rok vydání:	2010
Předmět:	Peg-interferon Ribavirin HCV genotype 3 Short treatment
Popis:	Background & Aims: The benefit of individualizing treatment for patients with genotype 3 HCV infection on the basis of viral clearance at week 4 (wk4-R) has not been firmly established. Methods: Four hundred and fourteen patients received Peginterferon alpha-2b plus 1000–1200 mg of ribavirin daily according with body weight > or
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=od______3658::a029424a83129013ca6c92b7ce2935bd http://hdl.handle.net/10447/52170 Zobrazit plný text záznamu